Christmas Cannabis Rally Will Continue thru 2018 and EVIO is Uniquely Positioned for Rapid Growth.
Why we just experienced a Christmas rally in the cannabis sector and why it will continue through 2018:
The federal government just lifted the ban on medical marijuana, which is a major milestone on the road to the sector becoming mainstream. This “hands off” signal by the Feds provides investors the confidence they needed to inject major capital in to the sector.
http://nationalpainreport.com/congress-quietl...28775.html
The massive California market, begins selling recreational marijuana on 1/1/2018. New licenses will be granted steadily throughout 2018 and there will be a huge surge in demand throughout the year. To put things in perspective, California’s economy is the 6th largest economy in the World and is projected to reach $5-7 Billion dollars.
New Jersey is projected to legalize marijuana via legislature within the first 100 days per Governor Phil Murphy’s pledge. New Jersey is the second largest state to legalize marijuana and is a key state on the east coast. It’s close proximity to New York and Wall Street will further attract investment in to the cannabis sector.
Massachusetts will begin sales of recreational marijuana in July, becoming the first east coast state to sell recreational marijuana, further legitimizing the cannabis sector as an entire U.S. sector and not just a west coast movement.
Recreational marijuana will become legal in Canada in mid-2018, providing a further boost to the industry and it’s legitimacy.
Remaining Federal obstruction in the U.S. is likely to be swept away by practical considerations, like the tax revenue to be garnered from the industry, and popular opinion. In many ways this is similar to the end of the Prohibition era (of alcohol), which of course led to huge profits for the liquor industry.
We are on course to see 25–30% growth in the cannabis/marijuana industry per year for the next four years in the United States. That will make it the fastest growing industry in the world. Therefore. established companies in the cannabis sector, who after years of work have created distinct products and/or services - like testing - should steadily grow, as the cannabis sector is still in its infancy with years of rapid growth ahead of it.
Cannabis testing is poised to become a $1.4 billion market by itself, according to an estimate by High Times.
http://hightimes.com/business/marijuanas-next...b-testing/
Why EVIO Labs?
EVIO labs provides accredited testing services serving California, Oregon, Colorado, Massachusetts, and Florida and is positioned to grow in to a national brand as the sector grows.
EVIO maintains cannabis labs in five states, and it plans to have 18 labs by the end of 2018 that provide testing to ensure the quality and safety of the cannabis supply
The company’s goal is to become the industry’s largest cannabis testing company, says CEO
Serving the legalized cannabis industry, EVIO sees California becoming the biggest marketplace globally. Estimates are that the cannabis market there could reach $5-7 billion annually
https://www.networknewswire.com/evio-inc-evio...alization/
Website: http://eviolabs.com
Oregon - 5 labs
1 - EVIO Labs Portland previously known as GreenHaus Analytical Labs
1 - EVIO Labs Bend
1 - EVIO Labs Eugene previously known as Oregon Analytical Services
1 - EVIO Labs Medford previously known as Kenevir Labs
1 - EVIO Labs La Grande, which is four hour drive away from both our existing Portland and Bend locations, will serve as our regional spoke serving both industrial hemp and cannabis clients in Eastern Oregon.
Oregon is expected to reach $24M in cannabis testing revenue by 2020.
California - 3 labs
1 - EVIO Labs Yuba City previously known as Green Style Analytics serving Northern CA
1 - EVIO Labs Costa Mesa (Coming Soon). Strategically located to become our hub lab for all of Southern California. Conveniently located by the two major freeways, this facility will be the primary processing center for all of our spoke labs from San Diego, Inland Empire, San Bernardino and Los Angeles
https://globenewswire.com/news-release/2017/0...ornia.html
1 - EVIO Labs Berkley, previously known as C3 Labs, LLC. This pending acquisition fast tracks EVIO Labs' expansion into Northern California
https://www.marketwatch.com/story/evio-inc-to...11-9142149
California is expected to reach $176M in cannabis testing revenue by 2020.
Massachusetts - 1 lab
1 - EVIO Labs Massachusetts previously known as Virdis Analytical. There are currently 15 licensed Registered Marijuana Dispensaries operating in Massachusetts up from the 11 when we acquired Viridis. The number of pending licensees has increased from 101 to over 220 according to the Massachusetts Department of Health. Recreational marijuana will be available in the state commencing in July 2018. Many of Evio’s clients are already preparing for this forecasted increase in demand.
Massachusetts is expected to reach $24M in cannabis testing revenue by 2020.
Florida - 2 labs
1 - EVIO Labs Broward County
1 - EVIO Labs Alacua County (Opening Soon)
First Licensing Agreement executed leveraging the EVIO brand name.
https://www.accesswire.com/470437/Signal-Bay-...in-Florida
EVIO FL Website: https://eviolabsfl.com
Colorado - 1 lab
1 - Licensee, PhytaTech CO. Colorado location has recently attained ISO 17025 accreditation. ISO 17025 is the highest recognized quality standard in the world for calibration and testing laboratories.
https://globenewswire.com/news-release/2017/1...ation.html
Expansion
$3M in Working Capital for Expansion.
https://www.marketwatch.com/story/evio-inc-an...2017-12-06
Although the increase in share price last week has been significant, EVIO has a lot of runway for future growth and is still consider to be an undervalued opportunity by many investors.
https://technical420.com/cannabis-article/cal...ze-big-way
All stock recommendations and comments are my opinion only. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action. You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. I cannot guarantee its accuracy or validity, nor am I responsible for any errors or omissions which may have occurred.
1
